Doctors have placed a patient into suspended animation in a development which offers a glimpse of a pathway to singularity.
Earlier this month we reported...
The Longevity brain-race hots up, as governments and regulators respond.
It has been just over two months since Elon Musk’s brainchild, Neuralink, unveiled its ambitious...
Interview with Emil Hewage, Co-founder and CEO, BIOS
Emil Hewage is the Co-founder and CEO of BIOS. With a background of Neuroscience and Machine Learning;...
Elon Musk’s brain implant enables closed-loop motor control and interaction with devices and applications – this new platform has great potential for Longevity.
Elon Musk...
Kurzweil claims the Singularity will happen by 2045.
Futurist Ray Kurzweil, a director of engineering at Google and inventor has made his share of technological...
Tracked.bio develops AI computer vision system that tracks flies and mice to reduce man-hours and increase data collected in Longevity studies.
A Danish start-up aims...
Bigger certainly doesn't mean better when it comes to Quicksilver's nutraceutical delivery methods.
The COVID-19 pandemic has caused an upturn in the supplements industry; from...
Following an R&D collaboration that began last year, Japanese pharma Astellas has announced it will acquire bioelectronics firm iota in $304m deal.
Last year's R&D...
Extending skinspan with non-invasive senetherapeutic proprietary peptide.
OneSkin is a Longevity company on a mission to transform the way we think about skin. Today the...
![Ozone therapy recently hit the headlines as one of the many treatment options being examined to mitigate the effects of COVID-19 [1], but it is also showing great promise in the treatment of neurodegenerative conditions such as Alzheimer’s and Parkinson's.](https://www.longevity.technology/wp-content/uploads/2020/10/Ozone-therapyW-218x150.jpg "Stopping neurodegeneration in its tracks with ozone therapy")
